Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. (2011) 144:646–74. 10.1016/j.cell.2011.02.01321376230
Balkwill F, Mantovani A. Inflammation and cancer: back to virchow? Lancet. (2001) 357:539–45. 10.1016/S0140-6736(00)04046-011229684
Paget S. The distribution of secondary growths in cancer of the breast. Lancet. (1889) 133:571–3. 10.1016/S0140-6736(00)49915-0
Egeblad M, Nakasone ES, Werb Z. Tumors as organs: complex tissues that interface with the entire organism. Dev Cell. (2010) 18:884–901. 10.1016/j.devcel.2010.05.01220627072
Chen F, Zhuang X, Lin L, Yu P, Wang Y, Shi Y, et al. New horizons in tumor microenvironment biology: challenges and opportunities. BMC Med. (2015) 13:14–45. 10.1186/s12916-015-0278-725857315
Patel H, Nilendu P, Jahagirdar D, Pal JK, Sharma NK. Modulating secreted components of tumor microenvironment: a masterstroke in tumor therapeutics. Cancer Biol Ther. (2018) 19:3–12. 10.1080/15384047.2017.139453829219656
Denton AE, Roberts EW, Fearon DT. Stromal cells in the tumor microenvironment BT - stromal immunology. In: Owens B, Lakins M, editors. Stromal Immunology. Cham: Springer (2018). p. 99–114.
Neesse A, Bauer CA, Öhlund D, Lauth M, Buchholz M, Michl P, et al. Stromal biology and therapy in pancreatic cancer: ready for clinical translation? Gut. (2018) 68:159–71. 10.1136/gutjnl-2018-31645130177543
Polyak K, Kalluri R. The role of the microenvironment in mammary gland development and cancer. Cold Spring Harb Perspect Biol. (2010) 2:a003244. 10.1101/cshperspect.a00324420591988
Conklin MW, Keely PJ. Why the stroma matters in breast cancer. Cell Adhes Migr. (2012) 6:249–60. 10.4161/cam.2056722568982
Hynes RO. The extracellular matrix: not just pretty fibrils. Science. (2009) 326:1216–19. 10.1126/science.117600919965464
Hynes RO, Naba A. Overview of the matrisome–an inventory of extracellular matrix constituents and functions. Cold Spring Harb Perspect Biol. (2012) 4:a004903. 10.1101/cshperspect.a00490321937732
Oskarsson T. Extracellular matrix components in breast cancer progression and metastasis. Breast. (2013) 22(Suppl. 2):S66–72. 10.1016/j.breast.2013.07.01224074795
Xian X, Gopal S, Couchman JR. Syndecans as receptors and organizers of the extracellular matrix. Cell Tissue Res. (2010) 339:31–46. 10.1007/s00441-009-0829-319597846
Walker C, Mojares E, del Río Hernández A. Role of extracellular matrix in development and cancer progression. Int J Mol Sci. (2018) 19:3028–31. 10.3390/ijms1910302830287763
Yue B. Biology of the extracellular matrix: an overview. J Glaucoma. (2014) 23:S20–3. 10.1097/IJG.000000000000010825275899
Mouw JK, Ou G, Weaver VM. Extracellular matrix assembly: a multiscale deconstruction. Nat Publ Gr. (2014) 15:771–85. 10.1038/nrm390225370693
Theocharis AD, Manou D, Karamanos NK. The extracellular matrix as a multitasking player in disease. FEBS J. (2019) 286:2830–69. 10.1111/febs.1481830908868
Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci. (2010) 123:4195–200. 10.1242/jcs.02382021123617
Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. (2009) 139:891–906. 10.1016/j.cell.2009.10.02719931152
Venning FA, Wullkopf L, Erler JT. Targeting ECM disrupts cancer progression. Front Oncol. (2015) 5:224. 10.3389/fonc.2015.0022426539408
Gkretsi V, Stylianopoulos T. Cell adhesion and matrix stiffness: coordinating cancer cell invasion and metastasis. Front Oncol. (2018) 8:145. 10.3389/fonc.2018.0014529780748
Jinka R, Kapoor R, Sistla PG, Raj TA, Pande G. Alterations in cell-extracellular matrix interactions during progression of cancers. Int J Cell Biol. (2012) 2012:219196–8. 10.1155/2012/21919622262973
Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell. (2005) 8:241–54. 10.1016/j.ccr.2005.08.01016169468
Sulzmaier FJ, Jean C, Schlaepfer DD. FAK in cancer: mechanistic findings and clinical applications. Nat Rev Cancer. (2014) 14:598–610. 10.1038/nrc379225098269
Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. (2000) 100:57–70. 10.1016/S0092-8674(00)81683-910647931
Chang TT, Thakar D, Weaver VM. Force-dependent breaching of the basement membrane. Matrix Biol. (2017) 57–58:178–89. 10.1016/j.matbio.2016.12.00528025167
Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. (2014) 15:1243–53. 10.15252/embr.20143924625381661
Assent D, Bourgot I, Hennuy B, Geurts P, Noël A, Foidart J-M, et al. A membrane-type-1 matrix metalloproteinase (MT1-MMP) - discoidin domain receptor 1 axis regulates collagen-induced apoptosis in breast cancer cells. PLoS ONE. (2015) 10:e0116006. 10.1371/journal.pone.011600625774665
Maquoi E, Assent D, Detilleux J, Pequeux C, Foidart J-M, Noël A. MT1-MMP protects breast carcinoma cells against type i collagen-induced apoptosis. Oncogene. (2012) 31:480–93. 10.1038/onc.2011.24921706048
Saby C, Collin G, Sinane M, Buache E, Van Gulick L, Saltel F, et al. DDR1 and MT1-MMP expression levels are determinant for triggering BIK-mediated apoptosis by 3D type I collagen matrix in invasive basal-like breast carcinoma cells. Front Pharmacol. (2019) 10:462. 10.3389/fphar.2019.0046231130862
Exposito J-Y, Valcourt U, Cluzel C, Lethias C. The fibrillar collagen family. Int J Mol Sci. (2010) 11:407–26. 10.3390/ijms1102040720386646
Exposito J-Y, Cluzel C, Garrone R, Lethias C. Evolution of collagens. Anat Rec. (2002) 268:302–16. 10.1002/ar.1016212382326
Myllyharju J, Kivirikko KI. Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet. (2004) 20:33–43. 10.1016/j.tig.2003.11.00414698617
Ricard-Blum S, Ruggiero F. The collagen superfamily: from the extracellular matrix to the cell membrane. Pathol Biol. (2005) 53:430–42. 10.1016/j.patbio.2004.12.02416085121
Bateman JF, Boot-Handford RP, Lamandé SR. Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations. Nat Rev Genet. (2009) 10:173–83. 10.1038/nrg252019204719
Mayne R, Burgeson RE. Structure and function of collagen types. Orlando: Academic Press (1987).
Van der Rest M, Garrone R. Collagen family of proteins. FASEB J. (1991) 5:2814–23. 10.1096/fasebj.5.13.19161051916105
Ricard-Blum S. The collagen family. Cold Spring Harb Perspect Biol. (2011) 3:a004978. 10.1101/cshperspect.a00497821421911
Brodsky B, Persikov AV. Molecular structure of the collagen triple helix. Adv Protein Chem. (2005) 70:301–39. 10.1016/S0065-3233(05)70009-715837519
Lees JF, Tasab M, Bulleid NJ. Identification of the molecular recognition sequence which determines the type-specific assembly of procollagen. EMBO J. (1997) 65:908–16. 10.1093/emboj/16.5.9089118952
Hofmann H, Fietzek PP, Kuhn K. The role of polar and hydrophobic interactions for the molecular packing of type I collagen: a three-dimensional evaluation of the amino acid sequence. J Mol Biol. (1978) 125:137–65. 10.1016/0022-2836(78)90342-X731689
Hoffman GG, Branam AM, Huang G, Pelegri F, Cole WG, Wenstrup RM, et al. Characterization of the six zebrafish clade B fibrillar procollagen genes, with evidence for evolutionarily conserved alternative splicing within the pro-α1(V) C-propeptide. Matrix Biol. (2010) 29:261–75. 10.1016/j.matbio.2010.01.00620102740
Fang M, Jacob R, McDougal O, Oxford JT. Minor fibrillar collagens, variable regions alternative splicing, intrinsic disorder, and tyrosine sulfation. Protein Cell. (2012) 3:419–33. 10.1007/s13238-012-2917-522752873
Boot-Handford RP, Tuckwell DS, Plumb DA, Rock CF, Poulsom R. A novel and highly conserved collagen (pro(alpha)1(XXVII)) with a unique expression pattern and unusual molecular characteristics establishes a new clade within the vertebrate fibrillar collagen family. J Biol Chem. (2003) 278:31067–77. 10.1074/jbc.M212889200
Koch M, Schulze J, Hansen U, Ashwodt T, Keene DR, Brunken WJ, et al. A novel marker of tissue junctions, collagen XXII. J Biol Chem. (2004) 279:22514–21. 10.1074/jbc.M40053620015016833
von der Mark H, Aumailley M, Wick G, Fleischmajer R, Timpl R. Immunochemistry, genuine size tissue localization of collagen VI. Eur J Biochem. (1984) 142:493–502. 10.1111/j.1432-1033.1984.tb08313.x6432530
Shaw LM, Olsen BR. FACIT collagens: diverse molecular bridges in extracellular matrices. Trends Biochem Sci. (1991) 16:191–4. 10.1016/0968-0004(91)90074-61882421
Kadler KE, Baldock C, Bella J, Boot-Handford RP. Collagens at a glance. J Cell Sci. (2007) 120:1955–8. 10.1242/jcs.0345317550969
Gelse K. Collagens—structure, function, and biosynthesis. Adv Drug Deliv Rev. (2003) 55:1531–46. 10.1016/j.addr.2003.08.00214623400
Fleischmajer R, Perlish JS, Burgeson RE, Bahai FS, Timpl R. Type I and Type III collagen interactions during fibrillogenesisa. Ann N Y Acad Sci. (1990) 580:161–75. 10.1111/j.1749-6632.1990.tb17927.x2186689
Niyibizi C, Eyre DR. Bone Type V collagen: chain composition and location of a trypsin cleavage site. Connect Tissue Res. (2009) 20:247–50. 10.3109/030082089090238942612158
Mayne R. Cartilage collagens. what is their function, and are they involved in articular disease? Arthritis Rheum. (1989) 32:241–6. 10.1002/anr.17803203022649109
von der Mark K, Schöber S, Goodman SL. Integrins in cell migration BT - integrin Protocols. In: Howlett A, editor. Integrin Protocols. NJ: Humana Press (1999). p. 219–230.
Kivirikko KI, Kishida Y, Sakakibara S, Prockop DJ. Hydroxylation of (X-Pro-Gly)n by protocollagen proline hydroxylase effect of chain length, helical conformation and amino acid sequence in the substrate. Biochim Biophys Acta Protein Struct. (1972) 271:347–56. 10.1016/0005-2795(72)90209-75046811
Persikov AV, Ramshaw JAM, Kirkpatrick A, Brodsky B. Electrostatic interactions involving lysine make major contributions to collagen triple-helix stability. Biochemistry. (2005) 44:1414–22. 10.1021/bi048216r15683226
Fallas JA, Gauba V, Hartgerink JD. Solution structure of an ABC collagen heterotrimer reveals a single-register helix stabilized by electrostatic interactions. J Biol Chem. (2009) 284:26851–9. 10.2210/pdb2klw/pdb19625247
Bella J, Eaton M, Brodsky B, Berman HM. Crystal and molecular structure of a collagen-like peptide at 1.9 A resolution. Science. (1994) 266:75–81. 10.1126/science.76956997695699
Bourhis J-M, Mariano N, Zhao Y, Harlos K, Exposito J-Y, Jones EY, et al. Structural basis of fibrillar collagen trimerization and related genetic disorders. Nat Struct Mol Biol. (2012) 19:1031–6. 10.1038/nsmb.238923001006
Gillberg L, Berg S, de Verdier PJ, Lindbom L, Werr J, Hellstrom PM. Effective treatment of mouse experimental colitis by alpha 2 integrin antibody: comparison with alpha 4 antibody and conventional therapy. Acta Physiol. (2013) 207:326–36. 10.1111/apha.1201723009282
Ghatak S, Niland S, Schulz JN, Wang F, Eble JA, Leitges M, et al. Role of integrins α1β1 and α2β1 in wound and tumor angiogenesis in mice. Am J Pathol. (2016) 186:3011–27. 10.1016/j.ajpath.2016.06.02127639165
Bekhouche M, Colige A. The procollagen N-proteinases ADAMTS2, 3 and 14 in pathophysiology. Matrix Biol. (2015) 44–46:46–53. 10.1016/j.matbio.2015.04.00125863161
Vadon-Le Goff S, Hulmes DJS, Moali C. BMP-1/tolloid-like proteinases synchronize matrix assembly with growth factor activation to promote morphogenesis and tissue remodeling. Matrix Biol. (2015) 44–46:14–23. 10.1016/j.matbio.2015.02.00625701650
Hulmes DJS. Building collagen molecules, fibrils, and suprafibrillar structures. J Struct Biol. (2002) 137:2–10. 10.1006/jsbi.2002.445012064927
Porter S, Clark IM, Kevorkian L, Edwards DR. The ADAMTS metalloproteinases. Biochem J. (2005) 386:15–27. 10.1042/BJ2004042415554875
Hopkins DR, Keles S, Greenspan DS. The bone morphogenetic protein 1/Tolloid-like metalloproteinases. Matrix Biol. (2007) 26:508–23. 10.1016/j.matbio.2007.05.00417560775
Colige A, Ruggiero F, Vandenberghe I, Dubail J, Kesteloot F, Van Beeumen J, et al. Domains and maturation processes that regulate the activity of ADAMTS-2, a metalloproteinase cleaving the aminopropeptide of fibrillar procollagens types I–III and V. J Biol Chem. (2005) 280:34397–408. 10.1074/jbc.M50645820016046392
Le Goff C, Somerville RPT, Kesteloot F, Powell K, Birk DE, Colige AC, et al. Regulation of procollagen amino-propeptide processing during mouse embryogenesis by specialization of homologous ADAMTS proteases: insights on collagen biosynthesis and dermatosparaxis. Development. (2006) 133:1587–96. 10.1242/dev.0230816556917
Prockop DJ, Sieron AL, Li S-W. Procollagen N-proteinase and procollagen C-proteinase. Two unusual metalloproteinases that are essential for procollagen processing probably have important roles in development and cell signaling. Matrix Biol. (1998) 16:399–408. 10.1016/S0945-053X(98)90013-09524360
Prockop DJ, Fertala A. Inhibition of the self-assembly of collagen I into fibrils with synthetic peptides. Demonstration that assembly is driven by specific binding sites on the monomers. J Biol Chem. (1998) 273:15598–604. 10.1074/jbc.273.25.155989624151
Artym VV, Matsumoto K. Imaging cells in three-dimensional collagen matrix. Curr Protoc Cell Biol. (2010) 48:10.18.1-10.18.20. 10.1002/0471143030.cb1018s4820853341
Wenstrup RJ, Florer JB, Brunskill EW, Bell SM, Chervoneva I, Birk DE. Type V collagen controls the initiation of collagen fibril assembly. J Biol Chem. (2004) 279:53331–7. 10.1074/jbc.M40962220015383546
Yamauchi M, Sricholpech M. Lysine post-translational modifications of collagen. Essays Biochem. (2012) 52:113–33. 10.1042/bse052011322708567
Trackman PC. Enzymatic and non-enzymatic functions of the lysyl oxidase family in bone. Matrix Biol. (2016) 52–54:7–18. 10.1016/j.matbio.2016.01.00126772152
Mäki JM. Lysyl oxidases in mammalian development and certain pathological conditions. Histol Histopathol. (2009) 24:651–60. 10.14670/HH-24.65119283672
Lucero HA, Kagan HM. Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell Mol Life Sci. (2006) 63:2304–16. 10.1007/s00018-006-6149-916909208
Rucker RB, Murray J. Cross-linking amino acids in collagen and elastin. Am J Clin Nutr. (1978) 31:1221–36. 10.1093/ajcn/31.7.122127088
Orgel JP, Wess TJ, Miller A. The in situ conformation and axial location of the intermolecular cross-linked non-helical telopeptides of type I collagen. Structure. (2000) 8:137–42. 10.1016/S0969-2126(00)00089-710673433
Bruckner P. Suprastructures of extracellular matrices: paradigms of functions controlled by aggregates rather than molecules. Cell Tissue Res. (2009) 339:7–18. 10.1007/s00441-009-0864-019756756
Molnar J, Fong KSK, He QP, Hayashi K, Kim Y, Fong SFT, et al. Structural and functional diversity of lysyl oxidase and the LOX-like proteins. Biochim Biophys Acta Proteins Proteomics. (2003) 1647:220–24. 10.1016/S1570-9639(03)00053-012686136
Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. (1986) 315:1650–9. 10.1056/NEJM198612253152606
Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. (2012) 21:309–22. 10.1016/j.ccr.2012.02.02222439926
Bissell MJ, Hines WC. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med. (2011) 17:320–29. 10.1038/nm.232821383745
Pietras K, Östman A. Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res. (2010) 316:1324–31. 10.1016/j.yexcr.2010.02.04520211171
Collins MA, Bednar F, Zhang Y, Brisset J-C, Galbán S, Galbán CJ, et al. Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. J Clin Invest. (2012) 122:639–53. 10.1172/JCI5922722232209
Helms E, Onate MK, Sherman MH. Fibroblast heterogeneity in the pancreatic tumor microenvironment. Cancer Discov. (2020) 10:648–56. 10.1158/2159-8290.CD-19-135332014869
Pankova D, Chen Y, Terajima M, Schliekelman MJ, Baird BN, Fahrenholtz M, et al. Cancer-associated fibroblasts induce a collagen cross-link switch in tumor stroma. Mol Cancer Res. (2016) 14:287–95. 10.1158/1541-7786.MCR-15-030726631572
Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, et al. Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell. (2018) 33:463–79.e10. 10.1016/j.ccell.2018.01.01129455927
Bartoschek M, Oskolkov N, Bocci M, Lövrot J, Larsson C, Sommarin M, et al. Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. Nat Commun. (2018) 9:5150. 10.1038/s41467-018-07582-330514914
Vaughan MB, Howard EW, Tomasek JJ. Transforming growth factor-β1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res. (2000) 257:180–89. 10.1006/excr.2000.486910854066
Lopez JI, Kang I, You W-K, McDonald DM, Weaver VM. In situ force mapping of mammary gland transformation. Integr Biol. (2011) 3:910–21. 10.1039/c1ib00043h21842067
Acerbi I, Cassereau L, Dean I, Shi Q, Au A, Park C, et al. Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. Integr Biol. (2015) 7:1120–34. 10.1039/c5ib00040h25959051
Cox TR, Erler JT. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech. (2011) 4:165–78. 10.1242/dmm.00407721324931
Friedl P, Wolf K. Tube travel: the role of proteases in individual and collective cancer cell invasion. Cancer Res. (2008) 68:7247–9. 10.1158/0008-5472.CAN-08-078418794108
Gritsenko PG, Ilina O, Friedl P. Interstitial guidance of cancer invasion. J Pathol. (2012) 226:185–99. 10.1002/path.303122006671
Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. (2006) 4:215–23. 10.1186/1741-7015-4-3817190588
Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer. (2003) 3:921–30. 10.1038/nrc1231
Kraning-Rush CM, Carey SP, Lampi MC, Reinhart-King CA. Microfabricated collagen tracks facilitate single cell metastatic invasion in 3D. Integr Biol. (2013) 5:606–16. 10.1039/c3ib20196a23388698
Riching KM, Cox BL, Salick MR, Pehlke C, Riching AS, Ponik SM, et al. 3D collagen alignment limits protrusions to enhance breast cancer cell persistence. Biophys J. (2014) 107:2546–58. 10.1016/j.bpj.2014.10.03525468334
Wolf K, te Lindert M, Krause M, Alexander S, te Riet J, Willis AL, et al. Physical limits of cell migration: control by ECM space and nuclear deformation and tuning by proteolysis and traction force. J Cell Biol. (2013) 201:1069–84. 10.1083/jcb.20121015223798731
Pathak A, Kumar S. Independent regulation of tumor cell migration by matrix stiffness and confinement. Proc Natl Acad Sci USA. (2012) 109:10334–9. 10.1073/pnas.111807310922689955
Doyle AD, Petrie RJ, Kutys ML, Yamada KM. Dimensions in cell migration. Curr Opin Cell Biol. (2013) 25:642–9. 10.1016/j.ceb.2013.06.00423850350
Fenner J, Stacer AC, Winterroth F, Johnson TD, Luker KE, Luker GD. Macroscopic stiffness of breast tumors predicts metastasis. Sci Rep. (2014) 4:5512. 10.1038/srep0551224981707
Reid SE, Kay EJ, Neilson LJ, Henze AT, Serneels J, McGhee EJ, et al. Tumor matrix stiffness promotes metastatic cancer cell interaction with the endothelium. EMBO J. (2017) 36:2373–89. 10.15252/embj.20169491228694244
Harada T, Swift J, Irianto J, Shin J-W, Spinler KR, Athirasala A, et al. Nuclear lamin stiffness is a barrier to 3D migration, but softness can limit survival. J Cell Biol. (2014) 204:669–82. 10.1083/jcb.20130802924567359
Denais CM, Gilbert RM, Isermann P, McGregor AL, te Lindert M, Weigelin B, et al. Nuclear envelope rupture and repair during cancer cell migration. Science. (2016) 352:353–8. 10.1126/science.aad729727013428
Paul CD, Mistriotis P, Konstantopoulos K. Cancer cell motility: lessons from migration in confined spaces. Nat Rev Cancer. (2017) 17:131–40. 10.1038/nrc.2016.12327909339
Petrie RJ, Yamada KM. Multiple mechanisms of 3D migration: the origins of plasticity. Curr Opin Cell Biol. (2016) 42:7–12. 10.1016/j.ceb.2016.03.02527082869
Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K, et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol. (2007) 9:1392–400. 10.1038/ncb165818037882
Sharma P, Ng C, Jana A, Padhi A, Szymanski P, Lee JSH, et al. Aligned fibers direct collective cell migration to engineer closing and nonclosing wound gaps. Mol Biol Cell. (2017) 28:2579–88. 10.1091/mbc.e17-05-030528747440
Ray A, Slama ZM, Morford RK, Madden SA, Provenzano PP. Enhanced directional migration of cancer stem cells in 3D aligned collagen matrices. Biophys J. (2017) 112:1023–36. 10.1016/j.bpj.2017.01.00728297639
Malik R, Lelkes PI, Cukierman E. Biomechanical and biochemical remodeling of stromal extracellular matrix in cancer. Trends Biotechnol. (2015) 33:230–6. 10.1016/j.tibtech.2015.01.00425708906
Beacham DA, Cukierman E. Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression. Semin Cancer Biol. (2005) 15:329–41. 10.1016/j.semcancer.2005.05.00315970443
Conklin MW, Eickhoff JC, Riching KM, Pehlke CA, Eliceiri KW, Provenzano PP, et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. AJPA. (2011) 178:1221–32. 10.1016/j.ajpath.2010.11.07621356373
Conklin MW, Gangnon RE, Sprague BL, Van Gemert L, Hampton JM, Eliceiri KW, et al. Collagen alignment as a predictor of recurrence after ductal carcinoma in situ. Cancer Epidemiol Prev Biomarkers. (2018) 27:138–45. 10.1158/1055-9965.EPI-17-072029141852
Colpaert C, Vermeulen P, Jeuris W, van Beest P, Goovaerts G, Weyler J, et al. Early distant relapse in ‘node-negative’ breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour. J Pathol. (2001) 193:442–9. 10.1002/path.829
Ford AJ, Orbach SM, Rajagopalan P. Fibroblasts stimulate macrophage migration in interconnected extracellular matrices through tunnel formation and fiber alignment. Biomaterials. (2019) 209:88–102. 10.1016/j.biomaterials.2019.03.04431030083
Jia H, Janjanam J, Wu SC, Wang R, Pano G, Celestine M, et al. The tumor cell-secreted matricellular protein WISP1 drives pro-metastatic collagen linearization. EMBO J. (2019) 38:315–55. 10.15252/embj.201810130231294477
Lee H-O, Mullins SR, Franco-Barraza J, Valianou M, Cukierman E, Cheng JD. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells. BMC Cancer. (2011) 11:245. 10.1186/1471-2407-11-24521668992
Heldin C-H, Rubin K, Pietras K, Östman A. High interstitial fluid pressure — an obstacle in cancer therapy. Nat Rev Cancer. (2004) 4:806–13. 10.1038/nrc145615510161
de Fougerolles AR, Sprague AG, Nickerson-Nutter CL, Chi-Rosso G, Rennert PD, Gardner H, et al. Regulation of inflammation by collagen-binding integrins alpha1beta1 and alpha2beta1 in models of hypersensitivity and arthritis. J Clin Invest. (2000) 105:721–9. 10.1172/JCI791110727440
Naba A, Clauser KR, Hoersch S, Liu H, Carr SA, Hynes RO. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol Cell Proteomics. (2012) 11:M111.014647. 10.1074/mcp.M111.01464722159717
Naba A, Clauser KR, Lamar JM, Carr SA, Hynes RO. Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters. Elife. (2014) 3:e01308. 10.7554/eLife.0130824618895
Zahir N, Weaver VM. Death in the third dimension: apoptosis regulation and tissue architecture. Curr Opin Genet Dev. (2004) 14:71–80. 10.1016/j.gde.2003.12.00515108808
Jenkins MH, Croteau W, Mullins DW, Brinckerhoff CE. The BRAFV600E inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells. Matrix Biol. (2015) 48:66–77. 10.1016/j.matbio.2015.05.00725989506
Afik R, Zigmond E, Vugman M, Klepfish M, Shimshoni E, Pasmanik-Chor M, et al. Tumor macrophages are pivotal constructors of tumor collagenous matrix. J Exp Med. (2016) 213:2315–31. 10.1084/jem.2015119327697834
Drifka CR, Loeffler AG, Mathewson K, Keikhosravi A, Eickhoff JC, Liu Y, et al. Highly aligned stromal collagen is a negative prognostic factor following pancreatic ductal adenocarcinoma resection. Oncotarget. (2016) 7:76197–213. 10.18632/oncotarget.1277227776346
Hanley CJ, Noble F, Ward M, Bullock M, Drifka C, Mellone M, et al. A subset of myofibroblastic cancer-associated fibroblasts regulate collagen fiber elongation, which is prognostic in multiple cancers. Oncotarget. (2016) 7:6159–74. 10.18632/oncotarget.674026716418
Kehlet SN, Sanz-Pamplona R, Brix S, Leeming DJ, Karsdal MA, Moreno V. Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients. Sci Rep. (2016) 6:30599. 10.1038/srep3059927465284
Willumsen N, Bager CL, Leeming DJ, Smith V, Christiansen C, Karsdal MA, et al. Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer. Cancer Med. (2014) 3:1136–45. 10.1002/cam4.30325044252
Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. (2012) 196:395–406. 10.1083/jcb.20110214722351925
Bager CL, Willumsen N, Leeming DJ, Smith V, Karsdal MA, Dornan D, et al. Collagen degradation products measured in serum can separate ovarian and breast cancer patients from healthy controls: a preliminary study. Cancer Biomark. (2015) 15:783–8. 10.3233/CBM-15052026406420
Mammoto T, Jiang A, Jiang E, Panigrahy D, Kieran MW, Mammoto A. Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression. Am J Pathol. (2013) 183:1293–305. 10.1016/j.ajpath.2013.06.02623928381
Thangavelu PU, Krenács T, Dray E, Duijf PHG. In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion. Clin Epigenetics. (2016) 8:120. 10.1186/s13148-016-0290-627891193
Matte BF, Kumar A, Placone JK, Zanella VG, Martins MD, Engler AJ, et al. Matrix stiffness mechanically conditions EMT and migratory behavior of oral squamous cell carcinoma. J Cell Sci. (2019) 132:jcs224360. 10.1242/jcs.22436030559248
Wikman H, Vessella R, Pantel K. Cancer micrometastasis and tumour dormancy. APMIS. (2008) 116:754–70. 10.1111/j.1600-0463.2008.01033.x18834417
Barkan D, El Touny LH, Michalowski AM, Smith JA, Chu I, Davis AS, et al. Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res. (2010) 70:5706–16. 10.1158/0008-5472.CAN-09-235620570886
Brisson BK, Mauldin EA, Lei W, Vogel LK, Power AM, Lo A, et al. Type III collagen directs stromal organization and limits metastasis in a murine model of breast cancer. Am J Pathol. (2015) 185:1471–86. 10.1016/j.ajpath.2015.01.02925795282
Chintala SK, Sawaya R, Gokaslan ZL, Rao JS. The effect of type III collagen on migration and invasion of human glioblastoma cell lines in vitro. Cancer Lett. (1996) 102:57–63. 10.1016/0304-3835(96)04163-88603379
Ma H-P, Chang H-L, Bamodu OA, Yadav VK, Huang T-Y, Wu ATH, et al. Collagen 1A1 (COL1A1) is a reliable biomarker and putative therapeutic target for hepatocellular carcinogenesis and metastasis. Cancers. (2019) 11:786. 10.3390/cancers1106078631181620
Zhu H, Chen H, Wang J, Zhou L, Liu S. Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer. Onco Targets Ther. (2019) 12:3441–57. 10.2147/OTT.S19456831123405
Sun S, Wang Y, Wu Y, Gao Y, Li Q, Abdulrahman AA, et al. Identification of COL1A1 as an invasion-related gene in malignant astrocytoma. Int J Oncol. (2018) 53:2542–54. 10.3892/ijo.2018.456830272346
Liu J, Shen J-X, Wu H-T, Li X-L, Wen X-F, Du C-W, et al. Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target. Discov Med. (2018) 25:211–23. 29906404
Zhang Z, Wang Y, Zhang J, Zhong J, Yang R. COL1A1 promotes metastasis in colorectal cancer by regulating the WNT/PCP pathway. Mol Med Rep. (2018) 17:5037–42. 10.3892/mmr.2018.853329393423
He B, Lin X, Tian F, Yu W, Qiao B. MiR-133a-3p inhibits oral squamous cell carcinoma (OSCC) proliferation and invasion by suppressing COL1A1. J Cell Biochem. (2018) 119:338–46. 10.1002/jcb.2618228569392
Wang Q, Yu J. MiR-129-5p suppresses gastric cancer cell invasion and proliferation by inhibiting COL1A1. Biochem Cell Biol. (2018) 96:19–25. 10.1139/bcb-2016-025428482162
Ji J, Zhao L, Budhu A, Forgues M, Jia H-L, Qin L-X, et al. Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Hepatol. (2010) 52:690–7. 10.1016/j.jhep.2009.12.02520338660
Wang J, Gao P, Song Y, Sun J, Chen X, Yu H, et al. Prognostic value of gastric cancer-associated gene signatures: evidence based on a meta-analysis using integrated bioinformatics methods. J Cell Mol Med. (2018) 22:5743–7. 10.1111/jcmm.1382330133128
Yan Z, Xu W, Xiong Y, Cheng Y, Xu H, Wang Z, et al. Highly accurate two-gene signature for gastric cancer. Med Oncol. (2013) 30:584. 10.1007/s12032-013-0584-x23606240
Yue H, Wang J, Chen R, Hou X, Li J, Lu X. Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer. BMC Cancer. (2019) 19:1266. 10.1186/s12885-019-6470-y31888563
Engqvist H, Parris TZ, Kovács A, Nemes S, Werner Rönnerman E, De Lara S, et al. Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas. BMC Cancer. (2019) 19:912–28. 10.1186/s12885-019-6084-431533654
Januchowski R, Swierczewska M, Sterzynska K, Wojtowicz K, Nowicki M, Zabel M. Increased expression of several collagen genes is associated with drug resistance in ovarian cancer cell lines. J Cancer. (2016) 7:1295–310. 10.7150/jca.15371
Yuan L, Shu B, Chen L, Qian K, Wang Y, Qian G, et al. Overexpression of COL3A1 confers a poor prognosis in human bladder cancer identified by co-expression analysis. Oncotarget. (2017) 8:70508–20. 10.18632/oncotarget.1973329050298
Gao Y-F, Mao X-Y, Zhu T, Mao C-X, Liu Z-X, Wang Z-B, et al. COL3A1 and SNAP91: novel glioblastoma markers with diagnostic and prognostic value. Oncotarget. (2016) 7:70494–503. 10.18632/oncotarget.1203827655637
Wang X-Q, Tang Z-X, Yu D, Cui S-J, Jiang Y-H, Zhang Q, et al. Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma. Oncotarget. (2016) 7:8823–38. 10.18632/oncotarget.6815
Ren W, Zhang Y, Zhang L, Lin Q, Zhang J, Xu G. Overexpression of collagen type V α1 chain in human breast invasive ductal carcinoma is mediated by TGF-β1. Int J Oncol. (2018) 52:1694–704. 10.3892/ijo.2018.431729568948
Liu W, Wei H, Gao Z, Chen G, Liu Y, Gao X, et al. COL5A1 may contribute the metastasis of lung adenocarcinoma. Gene. (2018) 665:57–66. 10.1016/j.gene.2018.04.06629702185
Feng G, Ma H-M, Huang H-B, Li Y-W, Zhang P, Huang J-J, et al. Overexpression of COL5A1 promotes tumor progression and metastasis and correlates with poor survival of patients with clear cell renal cell carcinoma. Cancer Manag Res. (2019) 11:1263–74. 10.2147/CMAR.S18821630799953
Chen H-C, Tseng Y-K, Shu C-W, Weng T-J, Liou H-H, Yen L-M, et al. Differential clinical significance of COL5A1 and COL5A2 in tongue squamous cell carcinoma. J Oral Pathol Med. (2019) 48:468–76. 10.1111/jop.1286130972812
Wu M, Sun Q, Mo C-H, Pang J-S, Hou J-Y, Pang L-L, et al. Prospective molecular mechanism of COL5A1 in breast cancer based on a microarray, RNA sequencing and immunohistochemistry. Oncol Rep. (2019) 42:151–75. 10.3892/or.2019.714731059074
Zeng X-T, Liu X-P, Liu T-Z, Wang X-H. The clinical significance of COL5A2 in patients with bladder cancer: a retrospective analysis of bladder cancer gene expression data. Medicine. (2018) 97:e0091. 10.1097/MD.000000000001009129517678
Huang G, Ge G, Izzi V, Greenspan DS. α3 chains of type V collagen regulate breast tumour growth via glypican-1. Nat Commun. (2017) 8:14351. 10.1038/ncomms1435128102194
Wu Y-H, Chang T-H, Huang Y-F, Chen C-C, Chou C-Y. COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization. Oncotarget. (2015) 6:23748–63. 10.18632/oncotarget.425026087191
Shen L, Yang M, Lin Q, Zhang Z, Zhu B, Miao C. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance. Oncol Rep. (2016) 36:877–85. 10.3892/or.2016.486927373316
Jia D, Liu Z, Deng N, Tan TZ, Huang RY-J, Taylor-Harding B, et al. A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets. Cancer Lett. (2016) 382:203–14. 10.1016/j.canlet.2016.09.00127609069
Li A, Li J, Lin J, Zhuo W, Si J. COL11A1 is overexpressed in gastric cancer tissues and regulates proliferation, migration and invasion of HGC-27 gastric cancer cells in vitro. Oncol Rep. (2017) 37:333–40. 10.3892/or.2016.527628004111
Zhang B, Zhang C, Yang X, Chen Y, Zhang H, Liu J, et al. Cytoplasmic collagen XIαI as a prognostic biomarker in esophageal squamous cell carcinoma. Cancer Biol Ther. (2018) 19:364–72. 10.1080/15384047.2018.142391529333916
Sun D, Jin H, Zhang J, Tan X. Integrated whole genome microarray analysis and immunohistochemical assay identifies COL11A1, GJB2 and CTRL as predictive biomarkers for pancreatic cancer. Cancer Cell Int. (2018) 18:174–11. 10.1186/s12935-018-0669-x30410422
Toss MS, Miligy IM, Gorringe KL, Aleskandarany MA, Alkawaz A, Mittal K, et al. Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ. Mod Pathol. (2019) 32:1460–72. 10.1038/s41379-019-0286-931175327
Misawa K, Kanazawa T, Imai A, Endo S, Mochizuki D, Fukushima H, et al. Prognostic value of type XXII and XXIV collagen mRNA expression in head and neck cancer patients. Mol Clin Oncol. (2014) 2:285–91. 10.3892/mco.2013.23324649348
Wang F, Dong J, Zhang Y, Yue S, Guo H, Liang P, et al. Identification of novel diagnostic and prognostic biomarkers for hepatocellular carcinoma. Oncol Rep. (2019) 43:87–98. 10.3892/or.2019.741531789422
Nagy Á, Lánczky A, Menyhárt O, Gyorffy B. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep. (2018) 8:9227–9. 10.1038/s41598-018-29514-3
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. (2018) 68:7–30. 10.3322/caac.21442
Fane M, Weeraratna AT. How the ageing microenvironment influences tumour progression. Nat Rev Cancer. (2019) 20:89–106. 10.1038/s41568-019-0222-931836838
Panwar P, Lamour G, Mackenzie NCW, Yang H, Ko F, Li H, et al. Changes in structural-mechanical properties and degradability of collagen during aging-associated modifications. J Biol Chem. (2015) 290:23291–306. 10.1074/jbc.M115.64431026224630
Diridollou S, Vabre V, Berson M, Vaillant L, Black D, Lagarde JM, et al. Skin ageing: changes of physical properties of human skin in vivo. Int J Cosmet Sci. (2001) 23:353–62. 10.1046/j.0412-5463.2001.00105.x18498486
Fisher GJ, Kang S, Varani J, Bata-Csorgo Z, Wan Y, Datta S, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. (2002) 138:1462–70. 10.1001/archderm.138.11.146212437452
Oh J-H, Kim YK, Jung J-Y, Shin J, Kim KH, Cho KH, et al. Intrinsic aging- and photoaging-dependent level changes of glycosaminoglycans and their correlation with water content in human skin. J Dermatol Sci. (2011) 62:192–201. 10.1016/j.jdermsci.2011.02.00721477996
Marcos-Garcés V, Molina Aguilar P, Bea Serrano C, García Bustos V, Benavent Seguí J, Ferrández Izquierdo A, et al. Age-related dermal collagen changes during development, maturation and ageing - a morphometric and comparative study. J Anat. (2014) 225:98–108. 10.1111/joa.1218624754576
Simm A, Müller B, Nass N, Hofmann B, Bushnaq H, Silber R-E, et al. Protein glycation - between tissue aging and protection. Exp Gerontol. (2015) 68:71–75. 10.1016/j.exger.2014.12.01325536383
Monnier VM, Mustata GT, Biemel KL, Reihl O, Lederer MO, Zhenyu D, et al. Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on ‘a puzzle nearing resolution'. Ann N Y Acad Sci. (2005) 1043:533–44. 10.1196/annals.1333.06116037276
Aït-Belkacem D, Guilbert M, Roche M, Duboisset J, Ferrand P, Sockalingum G, et al. Microscopic structural study of collagen aging in isolated fibrils using polarized second harmonic generation. J Biomed Opt. (2012) 17:80501–6. 10.1117/1.JBO.17.8.08050623224157
Wilson SL, Guilbert M, Sulé-Suso J, Torbet J, Jeannesson P, Sockalingum GD, et al. A microscopic and macroscopic study of aging collagen on its molecular structure, mechanical properties, and cellular response. FASEB J. (2014) 28:14–25. 10.1096/fj.13-22757924025727
Guilbert M, Roig B, Terryn C, Garnotel R, Jeannesson P, Sockalingum GD, et al. Highlighting the impact of aging on type I collagen: label-free investigation using confocal reflectance microscopy and diffuse reflectance spectroscopy in 3D matrix model. Oncotarget. (2016) 7:8546–55. 10.18632/oncotarget.738526885896
Panwar P, Butler GS, Jamroz A, Azizi P, Overall CM, Brömme D. Aging-associated modifications of collagen affect its degradation by matrix metalloproteinases. Matrix Biol. (2018) 65:30–44. 10.1016/j.matbio.2017.06.00428634008
Saby C, Buache E, Brassart-Pasco S, El Btaouri H, Courageot M-P, Van Gulick L, et al. Type I collagen aging impairs discoidin domain receptor 2-mediated tumor cell growth suppression. Oncotarget. (2016) 7:24908–27. 10.18632/oncotarget.879527121132
Saby C, Rammal H, Magnien K, Buache E, Brassart-Pasco S, Van-Gulick L, et al. Age-related modifications of type I collagen impair DDR1-induced apoptosis in non-invasive breast carcinoma cells. Cell Adhes Migr. (2018) 12:335–47. 10.1080/19336918.2018.147218229733741
Alcaraz J, Carrasco JL, Millares L, Luis I-C, Fernández-Porras FJ, Martínez-Romero A, et al. Stromal markers of activated tumor associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer. Lung Cancer. (2019) 135:151–60. 10.1016/j.lungcan.2019.07.02031446988
Mayorca-Guiliani AE, Willacy O, Madsen CD, Rafaeva M, Heumüller SE, Bock F, et al. Decellularization and antibody staining of mouse tissues to map native extracellular matrix structures in 3D. Nat Protoc. (2019) 14:3395–425. 10.1038/s41596-019-0225-831705125
Rich L, Whittaker P. Collagen and picrosirius red staining: a polarized light assessment of fibrillar hue and spatial distribution. Braz J Morphol Sci. (2005) 22:97–104.
Friedl P, Maaser K, Klein CE, Niggemann B, Krohne G, Zänker KS. Migration of highly aggressive MV3 melanoma cells in 3-dimensional collagen lattices results in local matrix reorganization and shedding of alpha2 and beta1 integrins and CD44. Cancer Res. (1997) 57:2061–70. 9158006
Choi S, Friedrichs J, Song YH, Werner C, Estroff LA, Fischbach C. Intrafibrillar, bone-mimetic collagen mineralization regulates breast cancer cell adhesion and migration. Biomaterials. (2019) 198:95–106. 10.1016/j.biomaterials.2018.05.00229759731
Brightman AO, Rajwa BP, Sturgis JE, McCallister ME, Robinson JP, Harbin SLV. Time-lapse confocal reflection microscopy of collagen fibrillogenesis and extracellular matrix assembly in vitro. Biopolymers. (2000) 54:222–34. 10.1002/1097-0282(200009)54:3<222::AID-BIP80>3.0.CO;2-K10861383
Friedl P. Dynamic imaging of cellular interactions with extracellular matrix. Histochem Cell Biol. (2004) 122:183–90. 10.1007/s00418-004-0682-015258769
Wielowieyska-Szybinska D, Białek-Galas K, Podolec K, Wojas-Pelc A. The use of reflectance confocal microscopy for examination of benign and malignant skin tumors. Postepy Dermatol Alergol. (2014) 31:380–7. 10.5114/pdia.2014.4096125610353
Bozkurt A, Kose K, Alessi-Fox C, Dy JG, Brooks DH, Rajadhyaksha M. Unsupervised delineation of stratum corneum using reflectance confocal microscopy and spectral clustering. Skin Res Technol. (2017) 23:176–85. 10.1111/srt.1231627516408
Ahlgrimm-Siess V, Laimer M, Rabinovitz HS, Oliviero M, Hofmann-Wellenhof R, Marghoob AA, et al. Confocal microscopy in skin cancer. Curr Dermatol Rep. (2018) 7:105–18. 10.1007/s13671-018-0218-929780659
Abraham T, Hogg J. Lung alveolar wall disruption in three-dimensional space identified using second-harmonic generation multiphoton excitation fluorescence In: Vo-Dinh T, Grundfest WS, Mahadevan-Jansen A, editors. Advanced Biomedical Clinical Diagnostic Systems VIII. San Francisco, CA: International Society for Optics and Photonics (2010). 75550X.
Williams RM, Zipfel WR, Webb WW. Interpreting second-harmonic generation images of collagen I fibrils. Biophys J. (2005) 88:1377–86. 10.1529/biophysj.104.04730815533922
Mostaço-Guidolin L, Rosin NL, Hackett T-L. Imaging collagen in scar tissue: developments in second harmonic generation microscopy for biomedical applications. Int J Mol Sci. (2017) 18:1772. 10.3390/ijms1808177228809791
Han X, Burke RM, Zettel ML, Tang P, Brown EB. Second harmonic properties of tumor collagen: determining the structural relationship between reactive stroma and healthy stroma. Opt Express. (2008) 16:1846–59. 10.1364/OE.16.00184618542263
Lacomb R, Nadiarnykh O, Townsend SS, Campagnola PJ. Phase matching considerations in second harmonic generation from tissues: effects on emission directionality, conversion efficiency and observed morphology. Opt Commun. (2008) 281:1823–32. 10.1016/j.optcom.2007.10.04019343083
Roth S, Freund I. Optical second-harmonic scattering in rat-tail tendon. Biopolymers. (1981) 20:1271–90. 10.1002/bip.1981.3602006137284569
Zipfel WR, Williams RM, Webb WW. Nonlinear magic: multiphoton microscopy in the biosciences. Nat Biotechnol. (2003) 21:1369–77. 10.1038/nbt89914595365
Gailhouste L, Le Grand Y, Odin C, Guyader D, Turlin B, Ezan F, et al. Fibrillar collagen scoring by second harmonic microscopy: a new tool in the assessment of liver fibrosis. J Hepatol. (2010) 52:398–406. 10.1016/j.jhep.2009.12.00920149472
Bredfeldt JS, Liu Y, Pehlke CA, Conklin MW, Szulczewski JM, Inman DR, et al. Computational segmentation of collagen fibers from second-harmonic generation images of breast cancer. J Biomed Opt. (2014) 19:16007. 10.1117/1.JBO.19.1.01600724407500
Burke K. Using second harmonic generation to predict patient outcome in solid tumors. BMC Cancer. (2015) 15:929. 10.1186/s12885-015-1911-826603532
Suhonen H, Fernández M, Serimaa R, Suortti P. Simulation of small-angle x-ray scattering from collagen fibrils and comparison with experimental patterns. Phys Med Biol. (2005) 50:5401–16. 10.1088/0031-9155/50/22/01216264260
Ooi GJ, Fox J, Siu K, Lewis R, Bambery KR, McNaughton D, et al. Fourier transform infrared imaging and small angle x-ray scattering as a combined biomolecular approach to diagnosis of breast cancer. Med Phys. (2008) 35:2151–61. 10.1118/1.289039118561690
Nissi MJ, Töyräs J, Laasanen MS, Rieppo J, Saarakkala S, Lappalainen R, et al. Proteoglycan and collagen sensitive MRI evaluation of normal and degenerated articular cartilage. J Orthop Res. (2004) 22:557–64. 10.1016/j.orthres.2003.09.00815099635
Egnell L, Vidić I, Jerome NP, Bofin AM, Bathen TF, Goa PE. Stromal collagen content in breast tumors correlates with in vivo diffusion-weighted imaging: a comparison of multi B-value DWI with histologic specimen from benign and malignant breast lesions. J Magn Reson Imaging. (2019) 51:1868–87. 10.1002/jmri.2701831837076
Morris JL, Cross SJ, Lu Y, Kadler KE, Lu Y, Dallas SL, et al. Live imaging of collagen deposition during skin development and repair in a collagen I – GFP fusion transgenic zebrafish line. Dev Biol. (2018) 441:4–11. 10.1016/j.ydbio.2018.06.00129883658
Vogel W, Gish GD, Alves F, Pawson T. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell. (1997) 1:13–23. 10.1016/S1097-2765(00)80003-99659899
Fu HL, Valiathan RR, Arkwright R, Sohail A, Mihai C, Kumarasiri M, et al. Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling. J Biol Chem. (2013) 288:7430–37. 10.1074/jbc.R112.44415823335507
Barrow AD, Raynal N, Andersen TL, Slatter DA, Bihan D, Pugh N, et al. OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice. J Clin Invest. (2011) 121:3505–16. 10.1172/JCI4591321841309
Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood. (2003) 102:449–61. 10.1182/blood-2002-12-388212649139
Melander MC, Jurgensen HJ, Madsen DH, Engelholm LH, Behrendt N. The collagen receptor uPARAP/Endo180 in tissue degradation and cancer. Int J Oncol. (2015) 47:1177–88. 10.3892/ijo.2015.312026316068
Sprangers S, Everts V. Molecular pathways of cell-mediated degradation of fibrillar collagen. Matrix Biol. (2019) 75–76:190–200. 10.1016/j.matbio.2017.11.00829162487
Henriet E, Sala M, Abou Hammoud A, Tuariihionoa A, Di Martino J, Ros M, et al. Multitasking discoidin domain receptors are involved in several and specific hallmarks of cancer. Cell Adhes Migr. (2018) 12:363–77. 10.1080/19336918.2018.146515629701112
Gullberg D. I Domain Integrins. Dordrecht: Springer (2014).
Zeltz C, Orgel J, Gullberg D. Molecular composition and function of integrin-based collagen glues-introducing COLINBRIs. Biochim Biophys Acta. (2014) 1840:2533–48. 10.1016/j.bbagen.2013.12.02224361615
Heino J. Cellular signaling by collagen-binding integrins. Adv Exp Med Biol. (2014) 819:143–55. 10.1007/978-94-017-9153-3_1025023173
Hamaia S, Farndale RW. Integrin recognition motifs in the human collagens. Adv Exp Med Biol. (2014) 819:127–42. 10.1007/978-94-017-9153-3_925023172
Jokinen J, Dadu E, Nykvist P, Käpylä J, White DJ, Ivaska J, et al. Integrin-mediated cell adhesion to type I collagen fibrils. J Biol Chem. (2004) 279:31956–63. 10.1074/jbc.M40140920015145957
Eble JA, Golbik R, Mann K, Kuhn K. The alpha 1 beta 1 integrin recognition site of the basement membrane collagen molecule [alpha 1(IV)]2 alpha 2(IV). EMBO J. (1993) 12:4795–802. 10.1002/j.1460-2075.1993.tb06168.x8223488
Tulla M, Pentikainen OT, Viitasalo T, Kapyla J, Impola U, Nykvist P, et al. Selective binding of collagen subtypes by integrin alpha 1I, alpha 2I, and alpha 10I domains. J Biol Chem. (2001) 276:48206–12. 10.1074/jbc.M10405820011572855
Hamaia SW, Pugh N, Raynal N, Nemoz B, Stone R, Gullberg D, et al. Mapping of potent and specific binding motifs, GLOGEN and GVOGEA, for integrin alpha1beta1 using collagen toolkits II and III. J Biol Chem. (2012) 287:26019–28. 10.1074/jbc.M112.35314422654115
Kapyla J, Jaalinoja J, Tulla M, Ylostalo J, Nissinen L, Viitasalo T, et al. The fibril-associated collagen IX provides a novel mechanism for cell adhesion to cartilaginous matrix. J Biol Chem. (2004) 279:51677–87. 10.1074/jbc.M40941220015383545
Madamanchi A, Santoro SA, Zutter MM. Alpha2beta1 integrin. Adv Exp Med Biol. (2014) 819:41–60. 10.1007/978-94-017-9153-3_325023166
Carafoli F, Hamaia SW, Bihan D, Hohenester E, Farndale RW. An activating mutation reveals a second binding mode of the integrin alpha2 I domain to the GFOGER motif in collagens. PLoS ONE. (2013) 8:e69833. 10.1371/journal.pone.0069833
Camper L, Hellman U, Lundgren-Akerlund E. Isolation, cloning, and sequence analysis of the integrin subunit alpha10, a beta1-associated collagen binding integrin expressed on chondrocytes. J Biol Chem. (1998) 273:20383–9. 10.1074/jbc.273.32.203839685391
Tiger CF, Fougerousse F, Grundstrom G, Velling T, Gullberg D. α110β1 integrin is a receptor for interstitial collagens involved in cell migration and collagen reorganization on mesenchymal nonmuscle cells. Dev Biol. (2001) 237:116–29. 10.1006/dbio.2001.036311518510
Knight CG, Morton LF, Peachey AR, Tuckwell DS, Farndale RW, Barnes MJ. The collagen-binding A-domains of integrins alpha(1)beta(1) and alpha(2)beta(1) recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J Biol Chem. (2000) 275:35–40. 10.1074/jbc.275.1.3510617582
Sipilä KH, Drushinin K, Rappu P, Jokinen J, Salminen TA, Salo AM, et al. Proline hydroxylation in collagen supports integrin binding by two distinct mechanisms. J Biol Chem. 293:7645–58. 10.1074/jbc.RA118.00220029615493
Kubow KE, Vukmirovic R, Zhe L, Klotzsch E, Smith ML, Gourdon D, et al. Mechanical forces regulate the interactions of fibronectin and collagen I in extracellular matrix. Nat Commun. (2015) 6:8026. 10.1038/ncomms902626272817
Fiedler LR, Schonherr E, Waddington R, Niland S, Seidler DG, Aeschlimann D, et al. Decorin regulates endothelial cell motility on collagen I through activation of insulin-like growth factor I receptor and modulation of alpha2beta1 integrin activity. J Biol Chem. (2008) 283:17406–15. 10.1074/jbc.M71002520018413316
Zeltz C, Brezillon S, Kapyla J, Eble JA, Bobichon H, Terryn C, et al. Lumican inhibits cell migration through alpha2beta1 integrin. Exp Cell Res. (2010) 316:2922–31. 10.1016/j.yexcr.2010.08.00220705068
Zhu J, Madhurapantula RS, Kalyanasundaram A, Sabharwal T, Antipova O, Bishnoi SW, et al. Ultrastructural location and interactions of the immunoglobulin receptor binding sequence within fibrillar type I collagen. Int J Mol Sci. (2020) 21:4166. 10.3390/ijms2111416632545195
Seguin L, Desgrosellier JS, Weis SM, Cheresh DA. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends Cell Biol. (2015) 25:234–40. 10.1016/j.tcb.2014.12.00625572304
Hamidi H, Ivaska J. Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. (2018) 18:533–48. 10.1038/s41568-018-0038-z30002479
Zaidel-Bar R, Itzkovitz S, Ma'ayan A, Iyengar R, Geiger B. Functional atlas of the integrin adhesome. Nat Cell Biol. (2007) 9:858–67. 10.1038/ncb0807-85817671451
Humphries JD, Chastney MR, Askari JA, Humphries MJ. Signal transduction via integrin adhesion complexes. Curr Opin Cell Biol. (2019) 56:14–21. 10.1016/j.ceb.2018.08.00430195153
Horton ER, Byron A, Askari JA, Ng DHJ, Millon-Fremillon A, Robertson J, et al. Definition of a consensus integrin adhesome and its dynamics during adhesion complex assembly and disassembly. Nat Cell Biol. (2015) 17:1577–87. 10.1038/ncb325726479319
Shattil SJ, Kim C, Ginsberg MH. The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol. (2010) 11:288–300. 10.1038/nrm2871
Kechagia JZ, Ivaska J, Roca-Cusachs P. Integrins as biomechanical sensors of the microenvironment. Nat Rev Mol Cell Biol. 20:1–17. 10.1038/s41580-019-0134-231182865
Kagami S, Urushihara M, Kondo S, Loster K, Reutter W, Tamaki T, et al. Requirement for tyrosine kinase-ERK1/2 signaling in alpha 1 beta 1 integrin-mediated collagen matrix remodeling by rat mesangial cells. Exp Cell Res. (2001) 268:274–83. 10.1006/excr.2001.527911478853
Inoue O, Suzuki-Inoue K, Dean WL, Frampton J, Watson SP. Integrin alpha2beta1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCgamma2. J Cell Biol. (2003) 160:769–80. 10.1083/jcb.20020804312615912
Consonni A, Cipolla L, Guidetti G, Canobbio I, Ciraolo E, Hirsch E, et al. Role and regulation of phosphatidylinositol 3-kinase β in platelet integrin α2β1 signaling. Blood. (2012) 119:847–56. 10.1182/blood-2011-07-36499222106345
Guidetti GF, Bernardi B, Consonni A, Rizzo P, Gruppi C, Balduini C, et al. Integrin alpha2beta1 induces phosphorylation-dependent and phosphorylation-independent activation of phospholipase Cgamma2 in platelets: role of Src kinase and Rac GTPase. J Thromb Haemost. (2009) 7:1200–6. 10.1111/j.1538-7836.2009.03444.x
Chen X, Abair TD, Ibanez MR, Su Y, Frey MR, Dise RS, et al. Integrin alpha1beta1 controls reactive oxygen species synthesis by negatively regulating epidermal growth factor receptor-mediated Rac activation. Mol Cell Biol. (2007) 27:3313–26. 10.1128/MCB.01476-0617339338
Honoré S, Kovacic H, Pichard V, Briand C, Rognoni J-B. Alpha2beta1-integrin signaling by itself controls G1/S transition in a human adenocarcinoma cell line (Caco2): implication of NADPH oxidase-dependent production of ROS. Exp Cell Res. (2003) 285:59–71. 10.1016/S0014-4827(02)00038-112681287
Schulz JN, Zeltz C, Sorensen IW, Barczyk M, Carracedo S, Hallinger R, et al. Reduced granulation tissue and wound strength in the absence of alpha11beta1 integrin. J Invest Dermatol. (2015) 135:1435–44. 10.1038/jid.2015.2425634355
Harburger DS, Calderwood DA. Integrin signalling at a glance. J Cell Sci. (2009) 122:159–63. 10.1242/jcs.01809319118207
Bottcher RT, Veelders M, Rombaut P, Faix J, Theodosiou M, Stradal TE, et al. Kindlin-2 recruits paxillin and Arp2/3 to promote membrane protrusions during initial cell spreading. J Cell Biol. (2017) 216:3785–98. 10.1083/jcb.20170117628912124
Petrich BG, Marchese P, Ruggeri ZM, Spiess S, Weichert RA, Ye F, et al. Talin is required for integrin-mediated platelet function in hemostasis and thrombosis. J Exp Med. (2007) 204:3103–11. 10.1084/jem.2007180018086863
Salmela M, Jokinen J, Tiitta S, Rappu P, Cheng RH, Heino J. Integrin alpha2beta1 in nonactivated conformation can induce focal adhesion kinase signaling. Sci Rep. (2017) 7:3414. 10.1038/s41598-017-03640-w28611383
Rantala JK, Pouwels J, Pellinen T, Veltel S, Laasola P, Mattila E, et al. SHARPIN is an endogenous inhibitor of β1-integrin activation. Nat Cell Biol. (2011) 13:1315–24. 10.1038/ncb234021947080
Mattila E, Pellinen T, Nevo J, Vuoriluoto K, Arjonen A, Ivaska J. Negative regulation of EGFR signalling through integrin-alpha1beta1-mediated activation of protein tyrosine phosphatase TCPTP. Nat Cell Biol. (2005) 7:78–85. 10.1038/ncb120915592458
Ivaska J, Reunanen H, Westermarck J, Koivisto L, Kähäri VM, Heino J. Integrin alpha2beta1 mediates isoform-specific activation of p38 and upregulation of collagen gene transcription by a mechanism involving the alpha2 cytoplasmic tail. J Cell Biol. (1999) 147:401–16. 10.1083/jcb.147.2.401
Langholz O, Röckel D, Mauch C, Kozlowska E, Bank I, Krieg T, et al. Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins. J Cell Biol. (1995) 131:1903–15. 10.1083/jcb.131.6.19038557756
Ravanti L, Heino J, López-Otín C, Kähäri VM. Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. J Biol Chem. (1999) 274:2446–55. 10.1074/jbc.274.4.2446
Barczyk MM, Lu N, Popova SN, Bolstad AI, Gullberg D. alpha11beta1 integrin-mediated MMP-13-dependent collagen lattice contraction by fibroblasts: evidence for integrin-coordinated collagen proteolysis. J Cell Physiol. (2013) 228:1108–19. 10.1002/jcp.2426123065814
Lochter A, Navre M, Werb Z, Bissell MJ. alpha1 and alpha2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression. Mol Biol Cell. (1999) 10:271–82. 10.1091/mbc.10.2.2719950676
Yamada KM, Even-Ram S. Integrin regulation of growth factor receptors. Nat Cell Biol. (2002) 4:E75–6. 10.1038/ncb0402-e7511944037
Ivaska J, Heino J. Cooperation between integrins and growth factor receptors in signaling and endocytosis. Annu Rev Cell Dev Biol. (2011) 27:291–320. 10.1146/annurev-cellbio-092910-15401721663443
Schnittert J, Bansal R, Storm G, Prakash J. Integrins in wound healing, fibrosis and tumor stroma: high potential targets for therapeutics and drug delivery. Adv Drug Deliv Rev. (2018) 129:37–53. 10.1016/j.addr.2018.01.02029414674
Guha D, Saha T, Bose S, Chakraborty S, Dhar S, Khan P, et al. Integrin-EGFR interaction regulates anoikis resistance in colon cancer cells. Apoptosis. (2019) 24:958–71. 10.1007/s10495-019-01573-531641961
McCall-Culbreath KD, Li Z, Zutter MM. Crosstalk between the alpha2beta1 integrin and c-met/HGF-R regulates innate immunity. Blood. (2008) 111:3562–70. 10.1182/blood-2007-08-10766418198349
Primac I, Maquoi E, Blacher S, Heljasvaara R, Van Deun J, Smeland HY, et al. Stromal integrin alpha11 regulates PDGFR-beta signaling and promotes breast cancer progression. J Clin Invest. (2019) 130:4609–28. 10.1172/JCI12589031287804
Leitinger B. Discoidin domain receptor functions in physiological and pathological conditions. Int Rev Cell Mol Biol. (2014) 310:39–87. 10.1016/B978-0-12-800180-6.00002-524725424
Danen EHJ. Integrin signaling as a cancer drug target. ISRN Cell Biol. (2013) 201:14. 10.1155/2013/135164
Vachon PH. Integrin signaling, cell survival, and anoikis: distinctions, differences, and differentiation. J Signal Transduct. (2011) 2011:738137. 10.1155/2011/73813721785723
Conti JA, Kendall TJ, Bateman A, Armstrong TA, Papa-Adams A, Xu Q, et al. The desmoplastic reaction surrounding hepatic colorectal adenocarcinoma metastases aids tumor growth and survival via alphav integrin ligation. Clin Cancer Res. (2008) 14:6405–13. 10.1158/1078-0432.CCR-08-0816
Gardner H. Integrin alpha1beta1. Adv Exp Med Biol. (2014) 819:21–39. 10.1007/978-94-017-9153-3_225023165
Gardner H, Kreidberg J, Koteliansky V, Jaenisch R. Deletion of integrin alpha 1 by homologous recombination permits normal murine development but gives rise to a specific deficit in cell adhesion. Dev Biol. (1996) 175:301–13. 10.1006/dbio.1996.01168626034
Pozzi A, Wary KK, Giancotti FG, Gardner HA. Integrin alpha1beta1 mediates a unique collagen-dependent proliferation pathway in vivo. J Cell Biol. (1998) 142:587–94. 10.1083/jcb.142.2.5879679154
Zemmyo M, Meharra EJ, Kuhn K, Creighton-Achermann L, Lotz M. Accelerated, aging-dependent development of osteoarthritis in alpha1 integrin-deficient mice. Arthritis Rheum. (2003) 48:2873–80. 10.1002/art.1124614558093
Peng YW, Zallocchi M, Meehan DT, Delimont D, Chang B, Hawes N, et al. Progressive morphological and functional defects in retinas from alpha1 integrin-null mice. Invest Ophthalmol Vis Sci. (2008) 49:4647–54. 10.1167/iovs.08-201118614805
Conrad C, Boyman O, Tonel G, Tun-Kyi A, Laggner U, de Fougerolles A, et al. Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis. Nat Med. (2007) 13:836–42. 10.1038/nm160517603494
Ekholm E, Hankenson KD, Uusitalo H, Hiltunen A, Gardner H, Heino J, et al. Diminished callus size and cartilage synthesis in alpha 1 beta 1 integrin-deficient mice during bone fracture healing. AJPA. (2002) 160:1779–85. 10.1016/S0002-9440(10)61124-812000729
Williams AS, Kang L, Zheng J, Grueter C, Bracy DP, James FD, et al. Integrin alpha1-null mice exhibit improved fatty liver when fed a high fat diet despite severe hepatic insulin resistance. J Biol Chem. (2015) 290:6546–57. 10.1074/jbc.M114.61571625593319
Zent R, Yan X, Su Y, Hudson BG, Borza DB, Moeckel GW, et al. Glomerular injury is exacerbated in diabetic integrin alpha1-null mice. Kidney Int. (2006) 70:460–70. 10.1038/sj.ki.500035916775606
Chen X, Su Y, Fingleton B, Acuff H, Matrisian LM, Zent R, et al. An orthotopic model of lung cancer to analyze primary and metastatic NSCLC growth in integrin alpha1-null mice. Clin Exp Metastasis. (2005) 22:185–93. 10.1007/s10585-005-7453-816086239
Macias-Perez I, Borza C, Chen X, Yan X, Ibanez R, Mernaugh G, et al. Loss of integrin alpha1beta1 ameliorates Kras-induced lung cancer. Cancer Res. (2008) 68:6127–35. 10.1158/0008-5472.CAN-08-139518676835
Boudjadi S, Bernatchez G, Senicourt B, Beausejour M, Vachon PH, Carrier JC, et al. Involvement of the integrin alpha1beta1 in the progression of colorectal cancer. Cancers. (2017) 9:96. 10.3390/cancers908009628933766
Pozzi A, Moberg PE, Miles LA, Wagner S, Soloway P, Gardner HA. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci USA. (2000) 97:2202–7. 10.1073/pnas.04037849710681423
Schadendorf D, Fichtner I, Makki A, Alijagic S, Kupper M, Mrowietz U, et al. Metastatic potential of human melanoma cells in nude mice–characterisation of phenotype, cytokine secretion and tumour-associated antigens. Br J Cancer. (1996) 74:194–9. 10.1038/bjc.1996.3378688321
Schadendorf D, Gawlik C, Haney U, Ostmeier H, Suter L, Czarnetzki BM. Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours. J Pathol. (1993) 170:429–34. 10.1002/path.17117004058105045
Ratzinger S, Grassel S, Dowejko A, Reichert TE, Bauer RJ. Induction of type XVI collagen expression facilitates proliferation of oral cancer cells. Matrix Biol. (2011) 30:118–25. 10.1016/j.matbio.2011.01.00121251976
Koukoulis GK, Warren WH, Virtanen I, Gould VE. Immunolocalization of integrins in the normal lung and in pulmonary carcinomas. Hum Pathol. (1997) 28:1018–25. 10.1016/S0046-8177(97)90054-X9308725
Fukuda K, Saikawa Y, Yagi H, Wada N, Takahashi T, Kitagawa Y. Role of integrin alpha1 subunits in gastric cancer patients with peritoneal dissemination. Mol Med Rep. (2012) 5:336–40. 10.3892/mmr.2011.64222021051
Wu JE, Santoro SA. Complex patterns of expression suggest extensive roles for the alpha 2 beta 1 integrin in murine development. Dev Dyn. (1994) 199:292–314. 10.1002/aja.10019904057521231
Zutter MM, Santoro SA. Widespread histologic distribution of the alpha 2 beta 1 integrin cell-surface collagen receptor. AJPA. (1990) 137:113–20. 2164774
Holtkotter O, Nieswandt B, Smyth N, Muller W, Hafner M, Schulte V, et al. Integrin alpha 2-deficient mice develop normally, are fertile, but display partially defective platelet interaction with collagen. J Biol Chem. (2002) 277:10789–94. 10.1074/jbc.M11230720011788609
Chen J, Diacovo TG, Grenache DG, Santoro SA, Zutter MM. The alpha(2) integrin subunit-deficient mouse: a multifaceted phenotype including defects of branching morphogenesis and hemostasis. AJPA. (2002) 161:337–44. 10.1016/S0002-9440(10)64185-5
Barczyk M, Carracedo S, Gullberg D. Integrins. Cell Tissue Res. (2010) 339:269–80. 10.1007/s00441-009-0834-619693543
Stange R, Kronenberg D, Timmen M, Everding J, Hidding H, Eckes B, et al. Age-related bone deterioration is diminished by disrupted collagen sensing in integrin alpha2beta1 deficient mice. Bone. (2013) 56:48–54. 10.1016/j.bone.2013.05.00323680479
Zweers MC, Davidson JM, Pozzi A, Hallinger R, Janz K, Quondamatteo F, et al. Integrin alpha2beta1 is required for regulation of murine wound angiogenesis but is dispensable for reepithelialization. J Invest Dermatol. (2007) 127:467–78. 10.1038/sj.jid.570054616977325
Borza CM, Su Y, Chen X, Yu L, Mont S, Chetyrkin S, et al. Inhibition of integrin alpha2beta1 ameliorates glomerular injury. J Am Soc Nephrol. (2012) 23:1027–38. 10.1681/ASN.201104036722440900
Peters MA, Wendholt D, Strietholt S, Frank S, Pundt N, Korb-Pap A, et al. The loss of alpha2beta1 integrin suppresses joint inflammation and cartilage destruction in mouse models of rheumatoid arthritis. Arthritis Rheum. (2012) 64:1359–68. 10.1002/art.3348722083543
Ramirez NE, Zhang Z, Madamanchi A, Boyd KL, O'Rear LD, Nashabi A, et al. The alpha2beta1 integrin is a metastasis suppressor in mouse models and human cancer. J Clin Invest. (2011) 121:226–37. 10.1172/JCI4232821135504
Zuo XX, Yang Y, Zhang Y, Zhang ZG, Wang XF, Shi YG. Platelets promote breast cancer cell MCF-7 metastasis by direct interaction: surface integrin alpha2beta1-contacting-mediated activation of Wnt-beta-catenin pathway. Cell Commun Signal. (2019) 17:142. 10.1186/s12964-019-0464-x31699102
Ibaragi S, Shimo T, Hassan NM, Isowa S, Kurio N, Mandai H, et al. Induction of MMP-13 expression in bone-metastasizing cancer cells by type I collagen through integrin alpha1beta1 and alpha2beta1-p38 MAPK signaling. Anticancer Res. (2011) 31:1307–13. 21508380
Siret C, Terciolo C, Dobric A, Habib MC, Germain S, Bonnier R, et al. Interplay between cadherins and alpha2beta1 integrin differentially regulates melanoma cell invasion. Br J Cancer. (2015) 113:1445–53. 10.1038/bjc.2015.35826512877
Sottnik JL, Daignault-Newton S, Zhang X, Morrissey C, Hussain MH, Keller ET, et al. Integrin alpha2beta 1 (alpha2beta1) promotes prostate cancer skeletal metastasis. Clin Exp Metastasis. (2013) 30:569–78. 10.1007/s10585-012-9561-623242739
Naci D, El Azreq MA, Chetoui N, Lauden L, Sigaux F, Charron D, et al. α2β1 integrin promotes chemoresistance against doxorubicin in cancer cells through extracellular signal-regulated kinase (ERK). J Biol Chem. (2012) 287:17065–76. 10.1074/jbc.M112.34936522457358
Naci D, Berrazouane S, Barabe F, Aoudjit F. Cell adhesion to collagen promotes leukemia resistance to doxorubicin by reducing DNA damage through the inhibition of Rac1 activation. Sci Rep. (2019) 9:19455. 10.1038/s41598-019-55934-w31857649
Naci D, Vuori K, Aoudjit F. Alpha2beta1 integrin in cancer development and chemoresistance. Semin Cancer Biol. (2015) 35:145–53. 10.1016/j.semcancer.2015.08.00426297892
Varas L, Ohlsson LB, Honeth G, Olsson A, Bengtsson T, Wiberg C, et al. Alpha10 integrin expression is up-regulated on fibroblast growth factor-2-treated mesenchymal stem cells with improved chondrogenic differentiation potential. Stem Cells Dev. (2007) 16:965–78. 10.1089/scd.2007.004918047418
Lundgren-Akerlund E, Aszodi A. Integrin alpha10beta1: a collagen receptor critical in skeletal development. Adv Exp Med Biol. (2014) 819:61–71. 10.1007/978-94-017-9153-3_425023167
Kyostila K, Lappalainen AK, Lohi H. Canine chondrodysplasia caused by a truncating mutation in collagen-binding integrin alpha subunit 10. PLoS ONE. (2013) 8:e75621. 10.1371/journal.pone.007562124086591
Wenke AK, Kjellman C, Lundgren-Akerlund E, Uhlmann C, Haass NK, Herlyn M, et al. Expression of integrin alpha10 is induced in malignant melanoma. Cell Oncol. (2007) 29:373–86. 10.1097/00008390-200609001-0019217726260
Munksgaard Thoren M, Chmielarska Masoumi K, Krona C, Huang X, Kundu S, Schmidt L, et al. Integrin α10, a novel therapeutic target in glioblastoma, regulates cell migration, proliferation, and survival. Cancers. (2019) 11:587. 10.3390/cancers1104058731027305
Okada T, Lee AY, Qin LX, Agaram N, Mimae T, Shen Y, et al. Integrin-alpha10 dependency identifies RAC and RICTOR as therapeutic targets in high-grade myxofibrosarcoma. Cancer Discov. (2016) 6:1148–65. 10.1158/2159-8290.CD-15-148127577794
Carracedo S, Lu N, Popova SN, Jonsson R, Eckes B, Gullberg D. The fibroblast integrin alpha11beta1 is induced in a mechanosensitive manner involving activin A and regulates myofibroblast differentiation. J Biol Chem. (2010) 285:10434–45. 10.1074/jbc.M109.078766
Popova SN, Rodriguez-Sanchez B, Liden A, Betsholtz C, Van Den Bos T, Gullberg D. The mesenchymal alpha11beta1 integrin attenuates PDGF-BB-stimulated chemotaxis of embryonic fibroblasts on collagens. Dev Biol. (2004) 270:427–42. 10.1016/j.ydbio.2004.03.00615183724
Zhu C-Q, Popova SN, Brown ER, Barsyte-Lovejoy D, Navab R, Shih W, et al. Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells. Proc Natl Acad Sci USA. (2007) 104:11754–9. 10.1073/pnas.070304010417600088
Popova SN, Barczyk M, Tiger CF, Beertsen W, Zigrino P, Aszodi A, et al. Alpha11 beta1 integrin-dependent regulation of periodontal ligament function in the erupting mouse incisor. Mol Cell Biol. (2007) 27:4306–16. 10.1128/MCB.00041-0717420280
Blumbach K, Niehoff A, Belgardt BF, Ehlen HW, Schmitz M, Hallinger R, et al. Dwarfism in mice lacking collagen-binding integrins alpha2beta1 and alpha11beta1 is caused by severely diminished IGF-1 levels. J Biol Chem. (2012) 287:6431–40. 10.1074/jbc.M111.28311922210772
Romaine A, Sorensen IW, Zeltz C, Lu N, Erusappan PM, Melleby AO, et al. Overexpression of integrin α11 induces cardiac fibrosis in mice. Acta Physiol. (2018) 222. 10.1111/apha.1293228771943
Navab R, Strumpf D, To C, Pasko E, Kim KS, Park CJ, et al. Integrin alpha11beta1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer. Oncogene. (2016) 35:1899–908. 10.1038/onc.2015.25426148229
Ando T, Kage H, Matsumoto Y, Zokumasu K, Yotsumoto T, Maemura K, et al. Integrin alpha11 in non-small cell lung cancer is associated with tumor progression and postoperative recurrence. Cancer Sci. (2020) 111:200–8. 10.1111/cas.1425731778288
Smeland HY, Askeland C, Wik E, Knutsvik G, Molven A, Edelmann RJ, et al. Integrin alpha11beta1 is expressed in breast cancer stroma and associates with aggressive tumor phenotypes. J Pathol Clin Res. (2019) 6:69–82. 10.1002/cjp2.14831605508
Smeland HY, Lu N, Karlsen TV, Salvesen G, Reed RK, Stuhr L. Stromal integrin alpha11-deficiency reduces interstitial fluid pressure and perturbs collagen structure in triple-negative breast xenograft tumors. BMC Cancer. (2019) 19:234. 10.1186/s12885-019-5449-z30876468
Boudjadi S, Carrier JC, Beaulieu JF. Integrin alpha1 subunit is up-regulated in colorectal cancer. Biomark Res. (2013) 1:16. 10.1186/2050-7771-1-1624252313
Boudjadi S, Carrier JC, Groulx JF, Beaulieu JF. Integrin alpha1beta1 expression is controlled by c-MYC in colorectal cancer cells. Oncogene. (2016) 35:1671–8. 10.1038/onc.2015.23126096932
Benya PD, Padilla SR. Modulation of the rabbit chondrocyte phenotype by retinoic acid terminates type II collagen synthesis without inducing type I collagen: the modulated phenotype differs from that produced by subculture. Dev Biol. (1986) 118:296–305. 10.1016/0012-1606(86)90096-53770304
Bengtsson T, Aszodi A, Nicolae C, Hunziker EB, Lundgren-Akerlund E, Fassler R. Loss of alpha10beta1 integrin expression leads to moderate dysfunction of growth plate chondrocytes. J Cell Sci. (2005) 118:929–36. 10.1242/jcs.0167815713743
Velling T, Kusche-Gullberg M, Sejersen T, Gullberg D. cDNA cloning and chromosomal localization of human alpha(11) integrin. A collagen-binding, I domain-containing, beta(1)-associated integrin alpha-chain present in muscle tissues. J Biol Chem. (1999) 274:25735–42. 10.1074/jbc.274.36.25735
Lu N, Carracedo S, Ranta J, Heuchel R, Soininen R, Gullberg D. The human alpha11 integrin promoter drives fibroblast-restricted expression in vivo and is regulated by TGF-beta1 in a Smad- and Sp1-dependent manner. Matrix Biol. (2010) 29:166–76. 10.1016/j.matbio.2009.11.003
Erusappan P, Alam J, Lu N, Zeltz C, Gullberg D. Integrin alpha11 cytoplasmic tail is required for FAK activation to initiate 3D cell invasion and ERK-mediated cell proliferation. Sci Rep. (2019) 9:15283. 10.1038/s41598-019-51689-631653900
Rombouts K, Carloni V. The fibrotic microenvironment as a heterogeneity facet of hepatocellular carcinoma. Fibrogenes Tissue Repair. (2013) 6:17. 10.1186/1755-1536-6-1724350713
Banys-Paluchowski M, Loibl S, Witzel I, Mundhenke C, Lederer B, Solbach C, et al. Clinical relevance of collagen protein degradation markers C3M and C4M in the serum of breast cancer patients treated with neoadjuvant therapy in the geparquinto trial. Cancers. (2019) 11:1186. 10.1055/s-0039-168793931443252
Willumsen N, Ali SM, Leitzel K, Drabick JJ, Yee N, Polimera HV, et al. Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer. Sci Rep. (2019) 9:19761. 10.1038/s41598-019-56268-331875000
Lipton A, Leitzel K, Ali SM, Polimera HV, Nagabhairu V, Marks E, et al. High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts. Int J Cancer. (2018) 143:3027–34. 10.1002/ijc.3162729923614
